AfterNext HealthTech Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants Commencing October 4, 2021
September 29 2021 - 4:42PM
Business Wire
AfterNext HealthTech Acquisition Corp. (“AfterNext” or “the
Company”) announced that, commencing October 4, 2021, holders of
the units sold in the Company’s initial public offering of
25,000,000 units completed on August 16, 2021 may elect to
separately trade the Class A ordinary shares and warrants included
in the units. Class A ordinary shares and warrants that are
separated will trade on the New York Stock Exchange under the
symbols “AFTR” and “AFTR WS,” respectively. Those units not
separated will continue to trade on the New York Stock Exchange
under the symbol “AFTR.U.” No fractional warrants will be issued
upon separation of the units, and only whole warrants will trade.
Holders of the units will need to have their brokers contact
Continental Stock Transfer & Trust Company, the Company's
transfer agent, in order to separate the units into Class A
ordinary shares and warrants.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the securities of the Company, nor
shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
The offering was made only by means of a prospectus. Copies of
the prospectus may be obtained from: Goldman Sachs & Co. LLC,
Attn: Prospectus Department, 200 West Street, New York, NY 10282,
email: prospectus-ny@ny.email.gs.com, tel: (866) 471-2526; Deutsche
Bank Securities Inc., Attn: Prospectus Group, 60 Wall Street, New
York, New York 10005-2836, email: prospectus.CPDG@db.com, tel:
(800) 503-4611; and BofA Securities, Attention: Prospectus
Department, NC1-004-03-43, 200 North College Street, 3rd Floor,
Charlotte, North Carolina 28255-0001 or email:
dg.prospectus_request@bofa.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute
“forward-looking statements.” All statements other than statements
of historical fact included in this press release are
forward-looking statements. When used in this press release, words
such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and
similar expressions, as they relate to us or our management team,
identify forward-looking statements. Forward-looking statements are
subject to numerous conditions, many of which are beyond the
control of the Company, including those set forth in the Risk
Factors section of the prospectus for the Company’s initial public
offering filed with the SEC. Copies are available on the SEC’s
website at www.sec.gov. The Company undertakes no obligation to
update these statements for revisions or changes after the date of
this press release, except as required by law.
About AfterNext HealthTech
AfterNext is a special purpose acquisition company focused on
the intersection of healthcare and technology and was formed for
the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business
combination with one or more businesses. Led by Halsey Wise and
Anthony Colaluca, in partnership with TPG, the Company intends to
focus on the industries that align with the background of its
founders and board, with a particular emphasis placed on the
HealthTech sector. For more information about AfterNext, please
visit www.AfterNextHealthTech.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210929005955/en/
Investor Contact: inquiries@afternexthealthtech.com
Media Contacts: For AfterNext HealthTech: Tom Johnson / Dan
Scorpio Abernathy MacGregor tbj@abmac.com / dps@abmac.com (917)
747-6990 / (646) 899-8118 For TPG: Luke Barrett and Courtney Power
media@tpg.com
AfterNext HealthTech Acq... (NYSE:AFTR.U)
Historical Stock Chart
From Nov 2024 to Dec 2024
AfterNext HealthTech Acq... (NYSE:AFTR.U)
Historical Stock Chart
From Dec 2023 to Dec 2024